NCT03676491
- Conditions
- Behavior, Behavioral Symptoms, Depression, +8 more
- Locations
-
- Unit for Depression, Psychiatry Aalborg, Denmark
Clinical trial condition
Behavioral Symptoms
Explore clinical trials studying Behavioral Symptoms. Study availability and eligibility vary by location and protocol.
9,563 public trials
1,395 recruiting studies
Behavioral Symptoms trial results
NCT03800303
- Conditions
- Behavior, Behavioral Symptoms, Depression, +1 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Completed
Social Media and COVID-19
NCT04367363
- Conditions
- Anxiety, Anxiety Disorders, Behavior, +18 more
- Locations
-
- Yale-NUS College Singapore
NCT04682275
- Conditions
- Behavior, Behavioral Symptoms, Coitus, +7 more
- Locations
-
- Necmettin Erbakan University Konya, Turkey (Türkiye)
NCT01163227
- Conditions
- Behavior, Behavioral Symptoms, Cognition Disorders, +13 more
- Locations
-
- PAREXEL (California Clinical Trials Medical Group), 1560 Chevy Chase Drive, Suite 140, Glendale, California, United States
- CRI Worldwide, 1113 Hospital Dr. Suite 202, Willingboro, New Jersey, United States
NCT01110902
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- University of Alabama at Birmingham, Department of Psychiatry Birmingham, Alabama, United States
- ATP Clinical Research Costa Mesa, California, United States
- Valley Clinical Research El Centro, California, United States
- Collaborative Neuroscience Network Garden Grove, California, United States
NCT00463242
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site National City, California, United States
- Novartis Investigative Site Orange, California, United States
- Novartis Investigative Site Pasadena, California, United States
Completed
Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
NCT00411099
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Scottsdale, Arizona, United States
- Novartis Investigative Site Little Rock, Arkansas, United States
- Novartis Investigative Site Cerritos, California, United States
- Novartis Investigative Site El Centro, California, United States
NCT01110889
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Birmingham Psychiatry Birmingham, Alabama, United States
- Southwestern Research Institute Beverly Hills, California, United States
- Pharmacology Research Institute Encino, California, United States
- Mood & Anxiety Research Fresno, California, United States
NCT00467402
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Peoria, Arizona, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Beverly Hills, California, United States